NanoAntibiotics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (19)

Latest Posts

About This Stock More About This Stock
NanoAntibiotics CEO Says His Firm Is Poised For Growth In Biotech's Potent Liver Disease Treatment Space
Article By: M.E. Garza
Thursday, July 7, 2016 1:03 PM EDT
Emerging small cap firm is pioneering CIPT Technology as a potential breakthrough for the treatment of ascites, a life-threatening complication of advanced liver cirrhosis.
In this article: NNAB Also: AVXL, ARWR, SYN, ICPT
Read

Latest Tweets for $NNAB

No tweets yet!

PARTNER HEADLINES